News & Updates
Filter by Specialty:
Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths
Insulin resistance in young people with obesity is positively associated with an atherogenic lipoprotein/lipid profile and carotid intima-media thickness (cIMT), regardless of their glucose tolerance status, suggests a study.
Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths
20 Jun 2022
Dulaglutide: A new horizon for T2D treatment in kids
A once-weekly subcutaneous dose of the GLP-1* receptor agonist dulaglutide successfully controlled glycaemic levels in youths with type 2 diabetes (T2D) being treated with lifestyle modification with or without metformin or insulin, results of the multinational, phase III AWARD-PEDS** study showed.
Dulaglutide: A new horizon for T2D treatment in kids
18 Jun 2022
Tradition, conditioning influence parental perceptions of GERD in Asian infants
In the first 3 months of a newborn’s life, the prevalence of gastroesophageal reflux disease (GERD) is at its peak, but most infants outgrow it by age 1 year, according to a Singapore study, noting that those breastfed at 3 weeks have a lower likelihood of GERD.
Tradition, conditioning influence parental perceptions of GERD in Asian infants
17 Jun 2022
Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma
A fixed-dose combination of albuterol and budesonide, delivered as needed, reduced the risk of severe exacerbations in patients with moderate-to-severe asthma inadequately controlled with corticosteroid maintenance therapy, according to results of the phase III MANDALA trial presented at ATS 2022.
